| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2008-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d85423fe39037ebff3d2cf6a8fb57dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9849dfc77f315597d643df299f6957e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b02d110d47d7efa7a38c988d1d5ff0a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5353ad7e86eb48867341b9b421e71f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf04da355b9987a69614bda3e49113c |
| publicationDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2688234-A1 |
| titleOfInvention |
Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| abstract |
The use of 4-phenyl-midazol-2-thiones as tyrosinase inhibitors for the preparation of pharmaceutical or cosmetic compositions for the treatment or prevention of pigment disorders. The present invention relates to the use of the compounds of general formula (I) below: (I) for the preparation of pharmaceutical or cosmetic compositions intended for the treatment or the prevention of pigment disorders. |
| priorityDate |
2007-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |